Dr Julia Brotherton

Senior Lecturer
Paediatrics & Child Health, Children's Hospital, Westmead

Telephone 9845 0651
Fax 9845 3095

Map

Selected grants

2008

  • A randomised trial of a web-based toolkit for applying evidence in the general practice cervical cancer prevention visit; Trevena L, McCaffery K, Barratt A, Leask J, Brotherton J, Dobbins T; Cancer Council New South Wales/Research Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Tabrizi, S., Brotherton, J., Stevens, M., Condon, J., McIntyre, P., Smith, D., Garland, S., et al (2014). HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. Journal Of Clinical Virology, 60(3), 250-256. [More Information]
  • Brotherton, J., Liu, B., Donovan, B., Kaldor, J., Saville, A. (2014). Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey. Vaccine, 32(5), 592-597. [More Information]
  • Brotherton, J., Murray, S., Hall, M., Andrewartha, L., Banks, C., Meijer, D., Pitcher, H., Scully, M., Molchanoff, L. (2013). Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Medical Journal of Australia, 199(9), 614-617. [More Information]
  • Macartney, K., Chiu, C., Georgousakis, M., Brotherton, J. (2013). Safety of human papillomavirus vaccines: a review. Drug Safety, 36(6), 393-412. [More Information]
  • Tabrizi, S., Brotherton, J., Kaldor, J., Skinner, R., Cummins, E., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Garland, S. (2012). Fall in Human Papillomavirus Prevalence Following a National Vaccination Program. The Journal of Infectious Diseases, 206(11), 1645-1651. [More Information]
  • Georgousakis, M., Jayasinghe, S., Brotherton, J., Gilroy, N., Chiu, C., Macartney, K. (2012). Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. The Lancet Infectious Diseases, 12(8), 627-634. [More Information]
  • Grulich, A., Hillman, R., Brotherton, J., Fairley, C. (2012). Time for a strategic research response to anal cancer. Sexual Health, 9(6), 628-631. [More Information]
  • Fairley, C., Brotherton, J., Hillman, R., Grulich, A. (2012). Why a special issue on anal cancer and what is in it? Sexual Health, 9(6), 501-503. [More Information]
  • Garland, S., Skinner, R., Brotherton, J. (2011). Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Preventive Medicine, 53, s29-s35. [More Information]
  • Garland, S., Brotherton, J., Condon, J., McIntyre, P., Stevens, M., David, S., Tabrizi, S. (2011). Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Medicine, 9(104), 1-13. [More Information]
  • Liu, B., Brotherton, J., Shellard, D., Donovan, B., Saville, A., Kaldor, J. (2011). Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods. BMC Medical Research Methodology, 11, 159. [More Information]
  • Brotherton, J., Gertig, D. (2011). Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact. Expert Review of Anti-infective Therapy, 9(8), 627-639. [More Information]
  • Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]
  • Jin, J., Stein, A., Conway, E., Regan, D., Law, M., Brotherton, J., Hocking, J., Grulich, A. (2011). Trends in anal cancer in Australia, 1982–2005. Vaccine, 29(12), 2322-2327. [More Information]
  • Cooper, S., Bernard, D., McCaffery, K., Brotherton, J., Skinner, R. (2010). "I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psychology, 29(6), 618-625. [More Information]
  • Cooper, S., Bernard, D., McCaffery, K., Brotherton, J., Garland, S., Skinner, R. (2010). "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Vaccine, 28(19), 3398-3408. [More Information]
  • Novakovic, D., Cheng, A., Cope, D., Brotherton, J. (2010). Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study. Sexual Health, 7(3), 253-261. [More Information]
  • Brotherton, J., Leask, J., Jackson, C., McCaffery, K., Trevena, L. (2010). National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Sexual Health, 7(3), 291-298. [More Information]
  • Quinn, H., McIntyre, P., Backhouse, J., Gidding, H., Brotherton, J., Gilbert, L. (2010). The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiology and Infection, 138(3), 426-433. [More Information]
  • Leask, J., Jackson, C., Trevena, L., McCaffery, K., Brotherton, J. (2009). Implementation of the Australian HPV vaccination program for adult women: Qualitative key informant interviews. Vaccine, 27(40), 5505-5512. [More Information]
  • Agorastos, T., Chatzigeorgiou, K., Brotherton, J., Garland, S. (2009). Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far. Vaccine, 27(52), 7270-7281.
  • Brotherton, J., Haywood, A., Heley, S. (2009). The incidence of genital warts in Australian women prior to the national vaccination program. Sexual Health, 6(3), 178-184. [More Information]
  • Brotherton, J., Kemp, A., McIntyre, P., Burgess, M., Gold, M., Campbell-Lloyd, S. (2008). Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ - Canadian Medical Association Journal, 179(6), 525-533. [More Information]
  • Brotherton, J. (2008). How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine, 26(2), 250-256. [More Information]
  • Garland, S., Brotherton, J., Skinner, R., Pitts, M., Saville, A., Mola, G., Jones, R. (2008). Human Papillomavirus and Cervical Cancer in Australasia and Oceania: Risk-factors, Epidemiology and Prevention. Vaccine, 26(Supplement 12), M80-M88.
  • Garland, S., Brotherton, J., Skinner, R., Pitts, M., Saville, M., Mola, G., Jones, R. (2008). Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Vaccine, 26, M80-8. [More Information]
  • Brotherton, J., Deeks, S., Campbell-Lloyd, S., Misrachi, A., Passaris, I., Peterson, K., Pitcher, H., Scully, M., Watson, M., Webby, R. (2008). Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Communicable Diseases Intelligence Quarterly Report, 32(4), 457-461. [More Information]
  • Brotherton, J., Gold, M. (2008). Monitoring vaccine safety: a critical component of every immunisation program. Medical Journal of Australia, 189(5), 243-244. [More Information]
  • Newall, A., Brotherton, J., Quinn, H., McIntyre, P., Backhouse, J., Gilbert, L., Esser, M., Erick, J., Bryan, J., Formica, N., MacIntyre, C. (2008). Population Seroprevalence of Human Papillo-mavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia. Clinical Infectious Diseases, 46(11), 1647-1655. [More Information]
  • Skinner, R., Brotherton, J. (2008). Sexual risk assessment is not helpful for recommendations on human papillomavirus vaccination. Therapy, 5(3), 283-287.
  • Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]
  • Schaffer, A., Brotherton, J., Booy, R. (2007). Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children? Journal of Paediatrics and Child Health, 43(9), 579-580. [More Information]
  • Brotherton, J., Taylor, R., Ivanov, O., Tewson, R., Page, A. (2007). It's much easier than going to the dentist: high levels of satisfaction in a mammography screening program. Australian and New Zealand Journal of Public Health, 31(4), 353-359. [More Information]
  • Brotherton, J., Wang, H., Schaffer, A., Quinn, H., Menzies, R., Hull, B., Lawrence, C., Wood, J., Wood, N., Rosewell, A., Newall, A., Macartney, K., Gidding, H., McIntyre, P., Booy, R., et al (2007). Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report, 31(Suppl June 2007), 1-152. [More Information]
  • Miller, M., Roche, P., Yohannes, K., Spencer, J., Bartlett, M., Brotherton, J., Hutchinson, J., Kirk, M., McDonald, A., Vadjic, C. (2005). Australia's notifiable diseases status, 2003 annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence Quarterly Report, 29(1), 1-61. [More Information]
  • Brotherton, J., Hull, B., Hayen, A., Gidding, H., Burgess, M. (2005). Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia. Pediatrics, 115(6), e643-e646. [More Information]
  • Brotherton, J., McIntyre, P. (2004). Planning for human papillomavirus vaccines in Australia: Report of a research group meeting. Communicable Diseases Intelligence Quarterly Report, 28(2), 249-254.
  • Brotherton, J., McIntyre, P., PUECH, M., Wang, H., Gidding, H., Hull, B., Lawrence, G., MacIntyre, C., Wood, N., Armstrong, D. (2004). Vaccine Preventable Diseases And Vaccination Coverage In Australia 2001 To 2002. Communicable Diseases Intelligence Quarterly Report, 28(Supplement 2), vii-S116.

2014

  • Tabrizi, S., Brotherton, J., Stevens, M., Condon, J., McIntyre, P., Smith, D., Garland, S., et al (2014). HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. Journal Of Clinical Virology, 60(3), 250-256. [More Information]
  • Brotherton, J., Liu, B., Donovan, B., Kaldor, J., Saville, A. (2014). Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey. Vaccine, 32(5), 592-597. [More Information]

2013

  • Brotherton, J., Murray, S., Hall, M., Andrewartha, L., Banks, C., Meijer, D., Pitcher, H., Scully, M., Molchanoff, L. (2013). Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Medical Journal of Australia, 199(9), 614-617. [More Information]
  • Macartney, K., Chiu, C., Georgousakis, M., Brotherton, J. (2013). Safety of human papillomavirus vaccines: a review. Drug Safety, 36(6), 393-412. [More Information]

2012

  • Tabrizi, S., Brotherton, J., Kaldor, J., Skinner, R., Cummins, E., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Garland, S. (2012). Fall in Human Papillomavirus Prevalence Following a National Vaccination Program. The Journal of Infectious Diseases, 206(11), 1645-1651. [More Information]
  • Georgousakis, M., Jayasinghe, S., Brotherton, J., Gilroy, N., Chiu, C., Macartney, K. (2012). Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. The Lancet Infectious Diseases, 12(8), 627-634. [More Information]
  • Grulich, A., Hillman, R., Brotherton, J., Fairley, C. (2012). Time for a strategic research response to anal cancer. Sexual Health, 9(6), 628-631. [More Information]
  • Fairley, C., Brotherton, J., Hillman, R., Grulich, A. (2012). Why a special issue on anal cancer and what is in it? Sexual Health, 9(6), 501-503. [More Information]

2011

  • Garland, S., Skinner, R., Brotherton, J. (2011). Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Preventive Medicine, 53, s29-s35. [More Information]
  • Garland, S., Brotherton, J., Condon, J., McIntyre, P., Stevens, M., David, S., Tabrizi, S. (2011). Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Medicine, 9(104), 1-13. [More Information]
  • Liu, B., Brotherton, J., Shellard, D., Donovan, B., Saville, A., Kaldor, J. (2011). Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods. BMC Medical Research Methodology, 11, 159. [More Information]
  • Brotherton, J., Gertig, D. (2011). Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact. Expert Review of Anti-infective Therapy, 9(8), 627-639. [More Information]
  • Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]
  • Jin, J., Stein, A., Conway, E., Regan, D., Law, M., Brotherton, J., Hocking, J., Grulich, A. (2011). Trends in anal cancer in Australia, 1982–2005. Vaccine, 29(12), 2322-2327. [More Information]

2010

  • Cooper, S., Bernard, D., McCaffery, K., Brotherton, J., Skinner, R. (2010). "I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psychology, 29(6), 618-625. [More Information]
  • Cooper, S., Bernard, D., McCaffery, K., Brotherton, J., Garland, S., Skinner, R. (2010). "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Vaccine, 28(19), 3398-3408. [More Information]
  • Novakovic, D., Cheng, A., Cope, D., Brotherton, J. (2010). Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study. Sexual Health, 7(3), 253-261. [More Information]
  • Brotherton, J., Leask, J., Jackson, C., McCaffery, K., Trevena, L. (2010). National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Sexual Health, 7(3), 291-298. [More Information]
  • Quinn, H., McIntyre, P., Backhouse, J., Gidding, H., Brotherton, J., Gilbert, L. (2010). The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiology and Infection, 138(3), 426-433. [More Information]

2009

  • Leask, J., Jackson, C., Trevena, L., McCaffery, K., Brotherton, J. (2009). Implementation of the Australian HPV vaccination program for adult women: Qualitative key informant interviews. Vaccine, 27(40), 5505-5512. [More Information]
  • Agorastos, T., Chatzigeorgiou, K., Brotherton, J., Garland, S. (2009). Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far. Vaccine, 27(52), 7270-7281.
  • Brotherton, J., Haywood, A., Heley, S. (2009). The incidence of genital warts in Australian women prior to the national vaccination program. Sexual Health, 6(3), 178-184. [More Information]

2008

  • Brotherton, J., Kemp, A., McIntyre, P., Burgess, M., Gold, M., Campbell-Lloyd, S. (2008). Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ - Canadian Medical Association Journal, 179(6), 525-533. [More Information]
  • Brotherton, J. (2008). How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine, 26(2), 250-256. [More Information]
  • Garland, S., Brotherton, J., Skinner, R., Pitts, M., Saville, A., Mola, G., Jones, R. (2008). Human Papillomavirus and Cervical Cancer in Australasia and Oceania: Risk-factors, Epidemiology and Prevention. Vaccine, 26(Supplement 12), M80-M88.
  • Garland, S., Brotherton, J., Skinner, R., Pitts, M., Saville, M., Mola, G., Jones, R. (2008). Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Vaccine, 26, M80-8. [More Information]
  • Brotherton, J., Deeks, S., Campbell-Lloyd, S., Misrachi, A., Passaris, I., Peterson, K., Pitcher, H., Scully, M., Watson, M., Webby, R. (2008). Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Communicable Diseases Intelligence Quarterly Report, 32(4), 457-461. [More Information]
  • Brotherton, J., Gold, M. (2008). Monitoring vaccine safety: a critical component of every immunisation program. Medical Journal of Australia, 189(5), 243-244. [More Information]
  • Newall, A., Brotherton, J., Quinn, H., McIntyre, P., Backhouse, J., Gilbert, L., Esser, M., Erick, J., Bryan, J., Formica, N., MacIntyre, C. (2008). Population Seroprevalence of Human Papillo-mavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia. Clinical Infectious Diseases, 46(11), 1647-1655. [More Information]
  • Skinner, R., Brotherton, J. (2008). Sexual risk assessment is not helpful for recommendations on human papillomavirus vaccination. Therapy, 5(3), 283-287.
  • Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]

2007

  • Schaffer, A., Brotherton, J., Booy, R. (2007). Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children? Journal of Paediatrics and Child Health, 43(9), 579-580. [More Information]
  • Brotherton, J., Taylor, R., Ivanov, O., Tewson, R., Page, A. (2007). It's much easier than going to the dentist: high levels of satisfaction in a mammography screening program. Australian and New Zealand Journal of Public Health, 31(4), 353-359. [More Information]
  • Brotherton, J., Wang, H., Schaffer, A., Quinn, H., Menzies, R., Hull, B., Lawrence, C., Wood, J., Wood, N., Rosewell, A., Newall, A., Macartney, K., Gidding, H., McIntyre, P., Booy, R., et al (2007). Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report, 31(Suppl June 2007), 1-152. [More Information]

2005

  • Miller, M., Roche, P., Yohannes, K., Spencer, J., Bartlett, M., Brotherton, J., Hutchinson, J., Kirk, M., McDonald, A., Vadjic, C. (2005). Australia's notifiable diseases status, 2003 annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence Quarterly Report, 29(1), 1-61. [More Information]
  • Brotherton, J., Hull, B., Hayen, A., Gidding, H., Burgess, M. (2005). Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia. Pediatrics, 115(6), e643-e646. [More Information]

2004

  • Brotherton, J., McIntyre, P. (2004). Planning for human papillomavirus vaccines in Australia: Report of a research group meeting. Communicable Diseases Intelligence Quarterly Report, 28(2), 249-254.
  • Brotherton, J., McIntyre, P., PUECH, M., Wang, H., Gidding, H., Hull, B., Lawrence, G., MacIntyre, C., Wood, N., Armstrong, D. (2004). Vaccine Preventable Diseases And Vaccination Coverage In Australia 2001 To 2002. Communicable Diseases Intelligence Quarterly Report, 28(Supplement 2), vii-S116.

To update your profile click here. For support on your academic profile contact .